Citation: Jcj. Eikenboom, Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology, BEST P R C, 14(2), 2001, pp. 365-379
Authors:
Goodeve, AC
Eikenboom, JCJ
Ginsburg, D
Hilbert, L
Mazurier, C
Peake, IR
Sadler, JE
Rodeghiero, F
Citation: Ac. Goodeve et al., A standard nomenclature for von Willebrand factor gene mutations and polymorphisms, THROMB HAEM, 85(5), 2001, pp. 929-931
Authors:
Kamphuisen, PW
Eikenboom, JCJ
Rosendaal, FR
Koster, T
Blann, AD
Vos, HL
Bertina, RM
Citation: Pw. Kamphuisen et al., High factor VIII antigen levels increase the risk of venous thrombosis butare not associated with polymorphisms in the von Willebrand factor and factor VIII gene, BR J HAEM, 115(1), 2001, pp. 156-158
Authors:
Bodo, I
Katsumi, A
Tuley, EA
Eikenboom, JCJ
Dong, ZY
Sadler, JE
Citation: I. Bodo et al., Type I von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins, BLOOD, 98(10), 2001, pp. 2973-2979
Citation: Pw. Kamphuisen et al., Factor V antigen levels and venous thrombosis - Risk profile, interaction with factor V Leiden, and relation with factor VIII antigen levels, ART THROM V, 20(5), 2000, pp. 1382-1386
Authors:
Castaman, G
Eikenboom, JCJ
Lattuada, A
Rodeghiero, F
Citation: G. Castaman et al., Grossly abnormal proteolysis of von Willebrand factor (VWF) in a patient heterozygous for a gene deletion and mutation in the dimerization area of VWF, THROMB HAEM, 84(4), 2000, pp. 729-730
Authors:
Castaman, G
Eikenboom, JCJ
Contri, A
Rodeghiero, F
Citation: G. Castaman et al., Pregnancy in women with type T von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130F, THROMB HAEM, 84(2), 2000, pp. 351-352
Authors:
Kamphuisen, PW
Lensen, R
Houwing-Duistermaat, JJ
Eikenboom, JCJ
Harvey, M
Bertina, RM
Rosendaal, FR
Citation: Pw. Kamphuisen et al., Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia, BR J HAEM, 109(3), 2000, pp. 519-522
Authors:
Castaman, G
Eikenboom, JCJ
Missiaglia, E
Rodeghiero, F
Citation: G. Castaman et al., Autosomal dominant type 1 von Willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effect, BR J HAEM, 108(4), 2000, pp. 876-879
Authors:
Castaman, G
Eikenboom, JCJ
Lattuada, A
Mannucci, PM
Rodeghiero, F
Citation: G. Castaman et al., Heightened proteolysis of the von Willebrand factor subunit in patients with von Willebrand disease hemizygous or homozygous for the C2362F mutation, BR J HAEM, 108(1), 2000, pp. 188-190
Authors:
Castaman, G
Eikenboom, JCJ
Bertina, RM
Rodeghiero, F
Citation: G. Castaman et al., Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation, THROMB HAEM, 82(3), 1999, pp. 1065-1070
Authors:
Kamphuisen, PW
Eikenboom, JCJ
Vos, HL
Pablo, R
Sturk, A
Bertina, RM
Rosendaal, FR
Citation: Pw. Kamphuisen et al., Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions, THROMB HAEM, 81(5), 1999, pp. 680-683